Boston Scientific to invest €26m in Irish facility


8 Aug 2011

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Medical device manufacturer Boston Scientific is to invest €26m in research and development at its facility in Clonmel, Co Tipperary, the company has announced.

The Government, through IDA Ireland, is supporting the investment.

The new funds will enable Boston Scientific to expand its R&D and technical capabilities regarding the design of its next-generation cardiac rhythm management devices manufactured at the Clonmel facility.

Enterprise Minister Richard Bruton said such investments not only create high-value jobs but also provide spin-off benefits for Irish businesses, researchers and the Irish economy.

Brad Sorenson, vice-president of operations for Boston Scientific, said the funding will benefit the company’s cariology, rhythm and vascular group by enhancing its ability to provide R&D, design and manufacturing support for its medical device technologies.  

"I am confident that, with the talent and expertise of our Clonmel staff, we can continue to successfully commercialise new life-saving innovations for our customers and their patients worldwide," Sorenson said.

In Ireland, Boston Scientific also has campuses in Clonmel, Galway and Cork.

66

DAYS

4

HOURS

26

MINUTES

Get your early bird tickets now!